vs
Ardmore Shipping Corp（ASC）与BillionToOne, Inc.（BLLN）财务数据对比。点击上方公司名可切换其他公司
BillionToOne, Inc.的季度营收约是Ardmore Shipping Corp的1.0倍（$83.5M vs $81.2M），Ardmore Shipping Corp净利率更高（15.7% vs 6.8%，领先8.9%），BillionToOne, Inc.同比增速更快（117.4% vs -15.5%）
阿德莫尔航运是一家全球化海上运输企业，持有并运营中型成品油轮与化学品运输船队，可为全球能源、化工及贸易领域客户提供石油产品、特种化学品及其他散装液态货物的海运服务。
BillionToOne, Inc.是一家生命科学与分子诊断企业，专注研发高精度基因检测解决方案，核心产品包括无创产前检测、肿瘤诊断试剂及罕见病筛查服务，服务全球多地的医疗机构、患者及科研合作方。
ASC vs BLLN — 直观对比
营收规模更大
BLLN
是对方的1.0倍
$81.2M
营收增速更快
BLLN
高出132.9%
-15.5%
净利率更高
ASC
高出8.9%
6.8%
损益表 — Q3 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $81.2M | $83.5M |
| 净利润 | $12.8M | $5.7M |
| 毛利率 | — | 69.9% |
| 营业利润率 | 16.1% | 11.5% |
| 净利率 | 15.7% | 6.8% |
| 营收同比 | -15.5% | 117.4% |
| 净利润同比 | -47.0% | 138.3% |
| 每股收益（稀释后） | $0.30 | $0.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASCBLLN
| Q3 25 | $81.2M | $83.5M | ||
| Q2 25 | $72.0M | — | ||
| Q1 25 | $74.0M | — | ||
| Q4 24 | — | $45.1M | ||
| Q3 24 | $96.1M | $38.4M | ||
| Q2 24 | $121.3M | — | ||
| Q1 24 | $106.3M | — | ||
| Q3 23 | $86.9M | — |
净利润ASCBLLN
| Q3 25 | $12.8M | $5.7M | ||
| Q2 25 | $9.6M | — | ||
| Q1 25 | $6.3M | — | ||
| Q4 24 | — | $-11.5M | ||
| Q3 24 | $24.1M | $-14.9M | ||
| Q2 24 | $62.7M | — | ||
| Q1 24 | $39.2M | — | ||
| Q3 23 | $21.2M | — |
毛利率ASCBLLN
| Q3 25 | — | 69.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 57.1% | ||
| Q3 24 | — | 52.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
营业利润率ASCBLLN
| Q3 25 | 16.1% | 11.5% | ||
| Q2 25 | 13.5% | — | ||
| Q1 25 | 8.6% | — | ||
| Q4 24 | — | 17.0% | ||
| Q3 24 | 25.4% | -32.9% | ||
| Q2 24 | 51.3% | — | ||
| Q1 24 | 37.2% | — | ||
| Q3 23 | 24.6% | — |
净利率ASCBLLN
| Q3 25 | 15.7% | 6.8% | ||
| Q2 25 | 13.3% | — | ||
| Q1 25 | 8.5% | — | ||
| Q4 24 | — | -25.5% | ||
| Q3 24 | 25.1% | -38.8% | ||
| Q2 24 | 51.7% | — | ||
| Q1 24 | 36.9% | — | ||
| Q3 23 | 24.4% | — |
每股收益（稀释后）ASCBLLN
| Q3 25 | $0.30 | $0.10 | ||
| Q2 25 | $0.22 | — | ||
| Q1 25 | $0.14 | — | ||
| Q4 24 | — | $-1.13 | ||
| Q3 24 | $0.55 | $-1.47 | ||
| Q2 24 | $1.47 | — | ||
| Q1 24 | $0.92 | — | ||
| Q3 23 | $0.49 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $195.2M |
| 总债务越低越好 | $116.1M | $55.0M |
| 股东权益账面价值 | $628.2M | $-239.5M |
| 总资产 | $799.8M | $327.5M |
| 负债/权益比越低杠杆越低 | 0.18× | — |
8季度趋势，按日历期对齐
现金及短期投资ASCBLLN
| Q3 25 | — | $195.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $191.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
总债务ASCBLLN
| Q3 25 | $116.1M | $55.0M | ||
| Q2 25 | $25.0M | — | ||
| Q1 25 | $20.5M | — | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | $22.5M | — | ||
| Q2 24 | $44.2M | — | ||
| Q1 24 | $23.1M | — | ||
| Q3 23 | $52.5M | — |
股东权益ASCBLLN
| Q3 25 | $628.2M | $-239.5M | ||
| Q2 25 | $618.3M | — | ||
| Q1 25 | $610.7M | — | ||
| Q4 24 | — | $-251.7M | ||
| Q3 24 | $627.0M | $-242.9M | ||
| Q2 24 | $617.7M | — | ||
| Q1 24 | $567.9M | — | ||
| Q3 23 | $517.0M | — |
总资产ASCBLLN
| Q3 25 | $799.8M | $327.5M | ||
| Q2 25 | $703.8M | — | ||
| Q1 25 | $690.4M | — | ||
| Q4 24 | — | $302.1M | ||
| Q3 24 | $722.8M | — | ||
| Q2 24 | $742.0M | — | ||
| Q1 24 | $704.1M | — | ||
| Q3 23 | $686.4M | — |
负债/权益比ASCBLLN
| Q3 25 | 0.18× | — | ||
| Q2 25 | 0.04× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.04× | — | ||
| Q2 24 | 0.07× | — | ||
| Q1 24 | 0.04× | — | ||
| Q3 23 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.9M | $13.8M |
| 自由现金流经营现金流 - 资本支出 | — | $6.5M |
| 自由现金流率自由现金流/营收 | — | 7.7% |
| 资本支出强度资本支出/营收 | — | 8.8% |
| 现金转化率经营现金流/净利润 | 1.40× | 2.42× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASCBLLN
| Q3 25 | $17.9M | $13.8M | ||
| Q2 25 | $11.2M | — | ||
| Q1 25 | $26.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $39.9M | — | ||
| Q2 24 | $48.4M | — | ||
| Q1 24 | $49.2M | — | ||
| Q3 23 | $42.0M | — |
自由现金流ASCBLLN
| Q3 25 | — | $6.5M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
自由现金流率ASCBLLN
| Q3 25 | — | 7.7% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
资本支出强度ASCBLLN
| Q3 25 | — | 8.8% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
现金转化率ASCBLLN
| Q3 25 | 1.40× | 2.42× | ||
| Q2 25 | 1.17× | — | ||
| Q1 25 | 4.20× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.65× | — | ||
| Q2 24 | 0.77× | — | ||
| Q1 24 | 1.25× | — | ||
| Q3 23 | 1.98× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASC
暂无分部数据
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
